SmartCells

About:

SmartCells develops insulin and polymer-based products for the treatment of diabetes, fertility, thyroid, and growth hormone deficiencies.

Website: http://www.smartinsulin.com

Top Investors: National Institutes of Health, Cherrystone Angel Group, National Institute of Diabetes and Digestive and Kidney Diseases, Beacon Angels, MIT Venture Mentoring Service (MIT VMS)

Description:

SmartCells, Inc. designs and develops insulin products. It offers SmartInsulin, a self regulating injectable formulation for treating diabetes. The company's polymer-based dosing technology is used for various applications, such as fertility, thyroid, and growth hormone deficiencies; treatments with poor compliance or therapeutic window issues, such as oncology; and drug-device combinations. SmartCells, Inc. was founded in 2003 and is based in Beverly, Massachusetts.